The pharmaceutical industry has had a rough go of it lately. Between negative headlines (with the recent Mylan EpiPen controversy only the latest controversy), congressional inquiries and calls from insurers and the medical community to defend the price of medications, today's value-focused healthcare landscape presents an unprecedented set of challenges for the sector.
In an age where we talk incessantly about the virtues of equality, local empowerment, engagement, freedom of choice, small business and democracy, the forces of monopoly seem to be gaining ground, sowing elitist seeds that make society's relationships more volatile. Surely none of us play a role in all of this - or do we?
My mother, who was once the primary caretaker of her husband and three kids, who worked as a substitute teacher and part time editor of the Harvard Business Review, who threw amazing parties and volunteered at the temple and ran a gourmet catering business in her spare time, has Alzheimer's Disease, just as her mother and brother had it before her.